Expansion of FasL-Expressing CD5<sup>+</sup> B Cells in Type 1 Diabetes Patients.

The frequency of FasL-expressing CD5 − B cells (FasL hi CD5 − ) was generally low and slightly higher in T1D, but the difference among the groups did not reach statistical significance (Figure 2 B).

also in 111,027 other papers